The obese patient
(Redirected from The Obese Patient)
Definitions
- BMI 25-29 = Overweight
- BMI 30-39 = Obese
- BMI 40-49 = Morbidly obese
- BMI >50 = Super obese
Dosing Scalars
- Total body weight (TBW)= Actual weight
- May result in over dosing
- Ideal body weight (IBW)= Calc. based on height & weight
- May result in under dosing
- Lean body weight (LBW)= Difference between TBW and fat mass
- Technically best weight scalar for drug administration but difficult to accurately measure
- Adjusted body weight (ABW) = Scalar derived from aminoglycoside pharmacokinetics (PK) in obesity
Estimating Patient Weight
There are multiple formulas to estimate weight - these are the most common:
- Estimated male TBW = 93.2 + 3.29[arm circumference (cm)] + 0.43[height (cm)]
- Estimated female TBW = 64.6 + 2.15[arm circumference (cm)] + 0.54[height (cm)]
- Estimated male IBW in kg = height in cm - 100
- More accurate IBW estimate:
- IBW (male) in kg = 50kg + 2.3kg for each in. over 5ft
- More accurate IBW estimate:
- Estimated female IBW in kg = height in cm - 105
- More accurate IBW estimate:
- IBW (female) in kg = 45kg + 2.3kg for each in. over 5ft
- More accurate IBW estimate:
- Estimated LBW = 1.3 x IBW
- Estimated ABW = IBW + [C x(TBW-IBW)]
- C = correction factor ususally 0.2 to 0.4
- Apps/Online resources:
- Epocrates has IBW calculator
- Http://www.medcalc.com/body.html
Medication Adjustments in Obesity
Obesity alters hepatic/renal clearance and volume of distribution (Vd) of many drugs
Medication | Dose Adjustment |
Morphine | Dose by IBW |
Fentanyl | Dose by LBW; Alternative: Initial dose TBW, subsequent dose by IBW (risk over dose when use TBW) |
Midazolam | Initial dose TBW, subsequent dose by IBW |
Propofol | Dose by LBW |
Etomidate | Dose by LBW |
Succinylcholine | Dose by TBW @ 1mg/kg |
Rocuronium | Dose by IBW |
Heparin | Same as non-obese patient (80U/kg followed by 18U/kg/h using TBW) |
Vancomycin | 30mg/kg TBW (then follow serum levels) |
Aminoglycosides | Dose by ABW (C= 0.4; then follow serum levels) |
Beta-lactams | No good data, may consider doubling dose |
Carbapenems | No empiric change recommended |
Antifungals | No empiric change recommended; use LBW when dosing weight-based agents |
Airway Management
Obesity associated with difficult bag-mask ventilation (BVM) and intubation
- Consider prolonged pre-oxygenation period and two provider BMV
- May improve lung function through use of pre-intubation period of NIPPV
- Obesity hypoventilation syndrome may cause chronic hypercapnia
- Place patient in "ramp" position
- Stack blankets behind patient's back to horizontally align external auditory meatus with sternal notch
- Consider Airtraq laryngoscope (shortened mean intubation time & desat episodes vs Mac DL in obese patients) OR other hyperangulated video laryngoscope such as glidescope
- Increased BMI associated with higher rate of developing ARDS
- Methods to improve oxygenation/ventilation:
- Use PEEP 10 to improve oxygenation if needed
- Place in reverse Trendelenburg ("beach chair" position) to improve ventilation
- Both may decrease CO so use cautiously in unstable patients
- Methods to improve oxygenation/ventilation:
Lumbar Puncture
- Obese patients have increased distance from skin to subarachnoid space
- Upright patient positioning improves LP success
- Estimated lumbar puncture depth (cm) = 1 + 17[weight(kg)/height(cm)]
- Ultrasound may improve identification of landmarks
- If failure, consider fluoroscopy-guided procedure by IR
References
- ↑ Venkat A, Ingrande J, and Lemmens HJM. Challenging & Emerging Conditions in EM. Dose adjustment of anaesthetics in the morbidly obese. British journal of anaesthesia. 2010; 105(suppl 1):i16-i23.